Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kodiak Sciences Inc (KOD)
NASDAQ:KOD
Holding KOD?
Track your performance easily
KOD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.59 - $7.77
Previous Close$4.76
Volume375.76K
Average Volume (3M)209.81K
Market Cap
$250.45M
Enterprise Value$106.98M
Total Cash (Recent Filing)$219.22M
Total Debt (Recent Filing)$75.76M
Price to Earnings (P/E)―
Beta3.42
Next Earnings
Nov 12, 2024EPS Estimate
-$0.91Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.77
Shares Outstanding52,614,729
10 Day Avg. Volume380,263
30 Day Avg. Volume209,809
Standard Deviation0.33
R-Squared0.13
Alpha0.00216
Financial Highlights & Ratios
Price to Book (P/B)1.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.63
Forecast
1Y Price Target
$2.67Price Target Upside-44.49% Downside
Rating ConsensusHold
Number of Analyst Covering4
Kodiak Sciences News
PremiumPre-Earnings
Is KOD a Buy, Before Earnings?
Ownership Overview
34.82% Insiders
8.56% Mutual Funds
0.71% Other Institutional Investors
48.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KOD FAQ
What was Kodiak Sciences Inc’s price range in the past 12 months?
Kodiak Sciences Inc lowest stock price was $1.59 and its highest was $7.77 in the past 12 months.
What is Kodiak Sciences Inc’s market cap?
Currently, no data Available
When is Kodiak Sciences Inc’s upcoming earnings report date?
Kodiak Sciences Inc’s upcoming earnings report date is Nov 12, 2024 which is in 3 days.
How were Kodiak Sciences Inc’s earnings last quarter?
Kodiak Sciences Inc released its earnings results on Aug 14, 2024. The company reported -$0.86 earnings per share for the quarter, beating the consensus estimate of -$0.872 by $0.012.
Is Kodiak Sciences Inc overvalued?
According to Wall Street analysts Kodiak Sciences Inc’s price is currently Overvalued.
Does Kodiak Sciences Inc pay dividends?
Kodiak Sciences Inc does not currently pay dividends.
What is Kodiak Sciences Inc’s EPS estimate?
Kodiak Sciences Inc’s EPS estimate is -$0.91.
How many shares outstanding does Kodiak Sciences Inc have?
Kodiak Sciences Inc has 52,614,730 shares outstanding.
What happened to Kodiak Sciences Inc’s price movement after its last earnings report?
Kodiak Sciences Inc reported an EPS of -$0.86 in its last earnings report, beating expectations of -$0.872. Following the earnings report the stock price went up 1.569%.
Which hedge fund is a major shareholder of Kodiak Sciences Inc?
Among the largest hedge funds holding Kodiak Sciences Inc’s share is Baker Bros Advisors LP. It holds Kodiak Sciences Inc’s shares valued at 41M.
---
Kodiak Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.67 (-44.49% Downside)
$2.67 (-44.49% Downside)
Hedge Fund Trend
Increased
By 29.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.8%
Last 30 Days ▲ 1.8%
Last 30 Days ▲ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
133.33%
12-Months-Change
Fundamentals
Return on Equity
-71.50%
Trailing 12-Months
Asset Growth
-31.90%
Trailing 12-Months
Company Description
Kodiak Sciences Inc
Kodiak Sciences, Inc. is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
---
KOD Company Deck
---
KOD Earnings Call
Q4 2024
0:00 / 0:00
---
KOD Stock 12 Month Forecast
Average Price Target
$2.67
▼(-44.49% Downside)
Technical Analysis
Apellis Pharmaceuticals
―
Atara Biotherapeutics
―
Fate Therapeutics
―
Allogene Therapeutics
―
Best Analysts Covering KOD
1 Year
1 Year Success Rate
11/15 ratings generated profit
1 Year Average Return
+40.39%
assigned a sell rating 2 months ago
Copying Gena Wang's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +40.39% per trade.
---